New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

HOUSTON, DECEMBER 4, 2025 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...

AdAlta Ltd. ( ($AU:1AD) ) has issued an announcement. AdAlta Limited announced the release of the Chair remarks and CEO presentation at their ...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to ...

In healthy brains, synaptic vesicles, or message-carrying bubbles within brain cells, help transfer information from cell to ...

Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period – --Cohort 7 Pharmacokinetic (PK) ...

This important study describes a deep learning framework that analyzes single-cell RNA data to identify a tumor-agnostic gene signature associated with brain metastases. The identified signature ...

Prescient Therapeutics Limited ( ($AU:PTX) ) has provided an announcement. Prescient Therapeutics Limited has secured Orphan Drug Designation from ...